OA-banner.jpg

STEM CELL THERAPY FOR OSTEOARTHRITIS

STEM CELL BANKING AND THERAPY IN INDIA

Stem Cell Banking and Research is our forte. With the technological know-how and expertise of banking from 10 different sources, ReeLabs is India's first and only bank with the capabilities to offer Amniotic Sac, Amniotic Fluid and Placental Stem Cell Banking facility along with Cord Blood and Cord Tissue. Our commitment to stem cells has successfully helped over 1,00,000 people from all walks of life. Our tie-ups with over 300 hospitals, medical centres and specialty clinics across India help us to be there for you whenever and wherever you need us. Using state of the art technology, we ensure the highest count and viability of cells, so that they can be effectively used for treatment, when required.

You can get in touch with us by filling out the contact form, or by giving us a call on our Toll Free no: 1800-222-454 (Mon-Fri, 10am-6pm).
 

OUR SERVICES

STEM CELL BANKING

Banking from 10 different sources and the only company in India to have the capabilities to bank stem cells from the Amniotic Sac, Amniotic Fluid and Placenta.

Banking-main1.jpg
Treatment-main1.jpg

STEM CELL THERAPY

From Leukaemia to Thalassemia, Stem Cell Therapy is the first line of treatment for over 80 approved disorders.

OUR STORY

We have devoted the past decade to establishing ReeLabs as a recognised authority in the field of stem cells. Using our proprietary technology, stem cells are processed to ensure they possess the best features.

OurStory-Home.jpg
Image by Jan Kopřiva

COVID-19

INDIA'S FIRST AND ONLY STEM CELL TRIAL AGAINST COVID-19

ReeLabs Pvt. Ltd. has received permission from the Central Licensing Authority to conduct the FIRST and ONLY clinical trial in India using Mesenchymal stem cells derived from Placenta and Umbilical Cord Tissue in the fight against COVID-19.

REELABS IN NUMBERS

10

PATENTS

7

CLINICAL TRIALS

15

PROPRIETARY INVENTIONS

300+

INTERNATIONAL PUBLICATIONS

RECOGNITION

MOST INNOVATIVE STEM CELL RESEARCH FACILITY

ReeLabs is a proud recipient of the Global Healthcare and Pharmaceutical Award, 2021 in the category of the 'Most Innovative Stem Cell Research Facility'!

ReeLabs is the first Asian Enterprise to have won this prestigious award.

GHP-Award.png